ECSTACY: A Review of MDMA and MDA

The Drug Enforcement Administration classified the drug methylenedioxymeth-amphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy...

Full description

Saved in:
Bibliographic Details
Published in:International journal of psychiatry in medicine 1987-12, Vol.16 (4), p.359-372
Main Authors: Climko, Robert P., Roehrich, Herbert, Sweeney, Donald R., Al-Razi, Jamil
Format: Article
Language:English
Subjects:
Ecstasy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Drug Enforcement Administration classified the drug methylenedioxymeth-amphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl group.
ISSN:0091-2174
1541-3527
DOI:10.2190/DCRP-U22M-AUMD-D84H